Literature DB >> 19608775

A treatable muscle disease.

Georgina Burke1, David Allen, Ramamurthy Arunachalam, David Beeson, Simon Hammans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19608775     DOI： 10.1136/jnnp.2009.181966

Source DB:  PubMed          Journal:  Pract Neurol        ISSN： 1474-7758


× No keyword cloud information.
  2 in total

Review 1.  Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.

Authors:  Charlotte Vrinten; Angeli M van der Zwaag; Stephanie S Weinreich; Rob J P M Scholten; Jan J G M Verschuuren
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

2.  Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.

Authors:  Ricardo A Maselli; Juan Arredondo; Orla Cagney; Jarae J Ng; Jennifer A Anderson; Colette Williams; Bae J Gerke; Betty Soliven; Robert L Wollmann
Journal:  Hum Mol Genet       Date:  2010-04-06       Impact factor: 6.150
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.